176 related articles for article (PubMed ID: 36962887)
1. The association between clinical, subclinical features and autoantibody profile in Vietnamese dermatomyositis patients.
Le MH; Dinh HT; Le TTH; Hoang PT; Vu MN; Le DH
PLOS Glob Public Health; 2023; 3(1):e0000979. PubMed ID: 36962887
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
[TBL] [Abstract][Full Text] [Related]
3. Trichoscopic, oral, and periungual fold findings as activity and damage markers in dermatomyositis patients and their correlation with myositis antibodies.
Salgueiro C; Poblete MJ; Robles-Silva C; Abarzúa Á; Vera-Kellet C
Arch Dermatol Res; 2023 Aug; 315(6):1603-1613. PubMed ID: 36757439
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry.
Hum RM; Lilleker JB; Lamb JA; Oldroyd AGS; Wang G; Wedderburn LR; Diederichsen LP; Schmidt J; Danieli MG; Oakley P; Griger Z; Phuong TNT; Kodishala C; Vazquez-Del Mercado M; Andersson H; De Paepe B; De Bleecker JL; Maurer B; McCann L; Pipitone N; McHugh N; New RP; Ollier WE; Krogh NS; Vencovsky J; Lundberg IE; ; Chinoy H
Rheumatology (Oxford); 2023 Sep; ():. PubMed ID: 37698987
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
Muro Y; Sugiura K; Akiyama M
Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
[TBL] [Abstract][Full Text] [Related]
6. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
8. Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis.
Gono T; Kuwana M
Expert Rev Clin Immunol; 2020 Jan; 16(1):79-89. PubMed ID: 31779485
[No Abstract] [Full Text] [Related]
9. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and immunological characteristics of 88 cases of overlap myositis].
Xiao YS; Zhu FY; Luo L; Xing XY; Li YH; Zhang XW; Shen DH
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1088-1093. PubMed ID: 34916687
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.
Ceribelli A; Fredi M; Taraborelli M; Cavazzana I; Tincani A; Selmi C; Chan JY; Chan EK; Satoh M; Franceschini F
Clin Exp Rheumatol; 2014; 32(6):891-7. PubMed ID: 25151986
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome].
Xing XY; Zhang JX; Zhu FY; Wang YF; Zhou XY; Li YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1214-1218. PubMed ID: 36533358
[TBL] [Abstract][Full Text] [Related]
14. Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies.
Ueda-Hayakawa I; Tonomura K; Maekawa A; Kaneda E; Arase N; Fujimoto M
J Dermatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 36890683
[TBL] [Abstract][Full Text] [Related]
15. Myositis autoantibodies in Iranian myositis patients: assessment the frequency and clinical relevancy.
Ebrahimi M; Rostamian A; Rafiei-Latianee R; Najafizadeh SR; Movaseghi S; Faezi ST; Ghazanfari T
Clin Rheumatol; 2022 Feb; 41(2):533-539. PubMed ID: 34514533
[TBL] [Abstract][Full Text] [Related]
16. Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.
Dunga SK; Kavadichanda C; Gupta L; Naveen R; Agarwal V; Negi VS
Rheumatol Int; 2022 Jul; 42(7):1155-1165. PubMed ID: 34050793
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Ueda-Hayakawa I; Hamaguchi Y; Okiyama N; Motegi S; Yamaoka T; Miyake S; Higashi A; Okamoto H; Takehara K; Fujimoto M
Br J Dermatol; 2019 Apr; 180(4):881-887. PubMed ID: 30120913
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and evaluation of dermatomyositis.
Marvi U; Chung L; Fiorentino DF
Indian J Dermatol; 2012 Sep; 57(5):375-81. PubMed ID: 23112358
[TBL] [Abstract][Full Text] [Related]
19. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
Chen X; Zhang L; Jin Q; Lu X; Lei J; Peng Q; Wang G; Ge Y
Front Immunol; 2022; 13():987841. PubMed ID: 36110863
[TBL] [Abstract][Full Text] [Related]
20. [Anti-MDA5 dermatomyositis. Literature review].
Castro-Molina SA; Méndez-Flores S
Rev Med Inst Mex Seguro Soc; 2023 Jan; 61(1):99-105. PubMed ID: 36542793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]